Cargando…
Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics
MicroRNAs (miRNAs) are small non-coding RNAs (18–24 nucleotides) that play significant roles in cell proliferation, development, invasion, cancer development, cancer progression, and anti-cancer drug resistance. miRNAs target multiple genes and play diverse roles. miRNAs can bind to the 3′UTR of tar...
Autores principales: | Jo, Hyein, Shim, Kyeonghee, Jeoung, Dooil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180509/ https://www.ncbi.nlm.nih.gov/pubmed/35682560 http://dx.doi.org/10.3390/ijms23115881 |
Ejemplares similares
-
The Potential of Senescence as a Target for Developing Anticancer Therapy
por: Jo, Hyein, et al.
Publicado: (2023) -
Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
por: Jo, Hyein, et al.
Publicado: (2022) -
Exosomes: Diagnostic and Therapeutic Implications in Cancer
por: Jo, Hyein, et al.
Publicado: (2023) -
Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
por: Shim, Kyeonghee, et al.
Publicado: (2023) -
HDAC2 as a target for developing anti-cancer drugs
por: Jo, Hyein, et al.
Publicado: (2023)